Acquired Immunodeficiency Syndrome

Pharmacology
Influence of the Cytochrome P450 2B6 Genotype on Population Pharmacokinetics of Efavirenz in Human Immunodeficiency Virus Patients
Salvador E. Cabrera, Dolores Santos, María P. Valverde, Alfonso Domínguez-Gil, Francisco González, Guillermo Luna, María J. García
Antiviral Agents
Predictive Value of Pharmacokinetics-Adjusted Phenotypic Susceptibility on Response to Ritonavir-Enhanced Protease Inhibitors (PIs) in Human Immunodeficiency Virus-Infected Subjects Failing Prior PI Therapy
Joseph J. Eron, Jeong-Gun Park, Richard Haubrich, Francesca Aweeka, Barbara Bastow, Gary E. Pakes, Song Yu, Hulin Wu, Douglas D. Richman
and for the ACTG5126 Study Team
Antiviral Agents
Genital Tract, Cord Blood, and Amniotic Fluid Exposures of Seven Antiretroviral Drugs during and after Pregnancy in Human Immunodeficiency Virus Type 1-Infected Women
Rosa F. Yeh, Naser L. Rezk, Angela D. M. Kashuba, Julie B. Dumond, Hiba L. Tappouni, Hsiao-Chuan Tien, Ya-Chi Chen, Manoli Vourvahis, Amanda L. Horton, Susan A. Fiscus, Kristine B. Patterson
LETTERS TO THE EDITOR
Both a Protective and a Deleterious Role for the L76V Mutation
Alessandra Tartaglia, Annalisa Saracino, Laura Monno, Carmine Tinelli, Gioacchino Angarano
Antiviral Agents
Safety and Activity of the Immune Modulator HE2000 on the Incidence of Tuberculosis and Other Opportunistic Infections in AIDS Patients
Dwight R. Stickney, Zoja Noveljic, Armando Garsd, Daniel A. Destiche, James M. Frincke
Antiviral Agents
Quality Assurance Program for Clinical Measurement of Antiretrovirals: AIDS Clinical Trials Group Proficiency Testing Program for Pediatric and Adult Pharmacology Laboratories
Diane T. Holland, Robin DiFrancesco, Judith Stone, Fayez Hamzeh, James D. Connor, Gene D. Morse
Antiviral Agents
Population Pharmacokinetics and Pharmacodynamics of Efavirenz, Nelfinavir, and Indinavir: Adult AIDS Clinical Trial Group Study 398
Marc Pfister, Line Labbé, Scott M. Hammer, John Mellors, Kara K. Bennett, Susan Rosenkranz, Lewis B. Sheiner
and the AIDS Clinical Trial Group Protocol 398 Investigators
AUTHOR'S CORRECTION
Effects of Gender, AIDS, and Acetylator Status on Intrapulmonary Concentrations of Isoniazid
John E. Conte, Jeffrey A. Golden, Mari McQuitty, Juliana Kipps, Sheila Duncan, Elaine McKenna, Elisabeth Zurlinden
Pharmacology
Effects of Gender, AIDS, and Acetylator Status on Intrapulmonary Concentrations of Isoniazid
John E. Conte, Jeffrey A. Golden, Mari McQuitty, Juliana Kipps, Sheila Duncan, Elaine McKenna, Elisabeth Zurlinden
Clinical Therapeutics
Antigen Clearance during Treatment of Disseminated Histoplasmosis with Itraconazole versus Fluconazole in Patients with AIDS
L. Joseph Wheat, Patricia Connolly, Nicholas Haddad, Ann Le Monte, Edward Brizendine, Richard Hafner

Main menu

User menu

Search

Acquired Immunodeficiency Syndrome

Pages